GW Pharmaceutical is looking to assure doctors that epilepsy treatment Epidiolex is vastly different from off-the-shelf artisan oils at cannabis shops.
The FDA just approved Epidiolex, the cannabis-based drug that GW Pharma has been toiling over for years, to treat two rare and serious forms of epilepsy.
In case anyone thought it was just the U.S. where pharma is accused of hiking prices, the U.K. has been quick to remind everyone it happens across the pond, hitting Pfizer with a £10,000 penalty.
